Does TAFASITAMAB Cause Dyspnoea? 21 Reports in FDA Database

Q: Does TAFASITAMAB cause Dyspnoea?

21 reports of Dyspnoea have been filed with the FDA for TAFASITAMAB, representing 1.5% of all TAFASITAMAB adverse event reports.

Q: How dangerous is Dyspnoea from TAFASITAMAB?

Of 21 reports, 9 (42.9%) resulted in death and 18 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Dyspnoea have been filed in association with TAFASITAMAB (MONJUVI). This represents 1.5% of all adverse event reports for TAFASITAMAB.

Reports of Dyspnoea with TAFASITAMAB

1.5%

of all TAFASITAMAB reports

Deaths

Hospitalizations

How Dangerous Is Dyspnoea From TAFASITAMAB?

Of the 21 reports, 9 (42.9%) resulted in death, 18 (85.7%) required hospitalization, and 1 (4.8%) were considered life-threatening.

Is Dyspnoea Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TAFASITAMAB. However, 21 reports have been filed with the FAERS database.

What Other Side Effects Does TAFASITAMAB Cause?

Disease progression (470) Diffuse large b-cell lymphoma (346) Off label use (203) Death (146) Neutropenia (99) Covid-19 (96) General physical health deterioration (75) Pneumonia (66) Febrile neutropenia (64) Drug ineffective (62)

What Other Drugs Cause Dyspnoea?

ALBUTEROL (21,856) TREPROSTINIL (16,348) AMBRISENTAN (13,367) PREDNISONE (12,830) BUDESONIDE\FORMOTEROL (11,158) TIOTROPIUM (10,863) ADALIMUMAB (10,547) DUPILUMAB (10,310) FLUTICASONE\SALMETEROL (9,783) MEPOLIZUMAB (9,192)

Which TAFASITAMAB Alternatives Have Lower Dyspnoea Risk?

TAFASITAMAB vs TAFASITAMAB-CXIX TAFASITAMAB vs TAFINLAR TAFASITAMAB vs TAFLUPROST TAFASITAMAB vs TAGRAXOFUSP-ERZS TAFASITAMAB vs TAHOR

TAFASITAMAB Full Profile All Dyspnoea Reports All Drugs Causing Dyspnoea TAFASITAMAB Demographics